Issue 1/2015

The contribution of TGF-β in Epithelial–Mesenchymal Transition (EMT): Down-regulation of E-cadherin via snail (1 — 15)

H. YU, Y. SHEN, J. HONG, Q. XIA, F. ZHOU, X. LIU

DOI: 10.4149/neo_2015_002

Cathepsin S as a cancer target (16 — 26)

L. ZHANG, H. WANG, J. XU

DOI: 10.4149/neo_2015_003

Changes in gene expression of CXCR4, CCR7 and BCL2 after treatment of breast cancer cells with saponin extract from Tribulus terrestris (27 — 33)

T. E. GORANOVA, S. S. BOZHANOV, V. S. LOZANOV, V. I. MITEV, R. P. KANEVA, E. I. GEORGIEVA

DOI: 10.4149/neo_2015_004

Knockdown of NF-κB p65 subunit expression suppresses growth of nude mouse lung tumor cell xenografts by activation of Bax apoptotic pathway (34 — 40)

Y. QU, X. ZHANG, R. WU

DOI: 10.4149/neo_2015_005

Fn14 receptor promotes invasive potential and metastatic capacity of non-small lung adenocarcinoma cells through the up-regulation of integrin α6 (41 — 52)

J. JANDOVA, C. J. MASON, S. C. PAWAR, G. S. WATTS

DOI: 10.4149/neo_2015_006

Microarray data analysis reveals differentially expressed genes in prolactinoma (53 — 60)

W. ZHOU, C. MA, Z. YAN

DOI: 10.4149/neo_2015_007

FOXM1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and mediates sensitivity to cisplatin in A549 cells via the JNK/mitochondrial pathway (61 — 71)

Y. LIU, X. CHEN, Y. GU, L. ZHU, Y. QIAN, D. PEI, W. ZHANG, Y. SHU

DOI: 10.4149/neo_2015_008

Association of PIK3CA gene mutations with head and neck squamous cell carcinomas (72 — 80)

N. KOMMINENI, K. JAMIL, U. R. PINGALI, L. ADDALA, V. M., M. NAIDU

DOI: 10.4149/neo_2015_009

Overexpression of Survivin mutant Thr34Ala induces apoptosis and inhibits gastric cancer growth (81 — 87)

S. C. DANG, S. FENG, P. J. WANG, L. CUI, J. G. QU, J. X. ZHANG

DOI: 10.4149/neo_2015_010

Correlation of carbonic anhydrase IX expression with clinico-morphological parameters, hormonal receptor status and HER-2 expression in breast cancer (88 — 97)

M. FURJELOVA, M. KOVALSKA, K. JURKOVA, J. CHYLIKOVA, V. MESTANOVA, M. ADAMKOV

DOI: 10.4149/neo_2015_011

Intracellular distribution of 3,6-bis(3-alkylguanidino)acridines determines their cytotoxicity (98 — 107)

L. KRAJNAKOVA, H. PAULIKOVA, Z. BACOVA, J. BAKOS, L. JANOVEC, J. IMRICH, L. HUNAKOVA

DOI: 10.4149/neo_2015_012

Associations between the Expression of micro-RNA 214 and clinicopathologic parameters of glioma (108 — 113)

W. WANG, H. YAN, F. TIAN, Y. SU, J. XU, C. DOU

DOI: 10.4149/neo_2015_013

Prognostic and predictive molecular biological markers in prostate cancer – significance of expression of genes PCA3 and TMPRSS2 (114 — 118)

R. SOUMAROVA, A. BODAY, V. KRHUTOVA, A. JANOTOVA, M. DVORAKOVA, E. JALUVKOVA, M. STURSA, H. PERKOVA

DOI: 10.4149/neo_2015_014

Antioxidant defense system in prostate adenocarcinoma and benign prostate hyperplasia of elderly patients (119 — 123)

K. SZEWCZYK-GOLEC, J. TYLOCH, J. CZUCZEJKO

DOI: 10.4149/neo_2015_015

Serum CYFRA21-1 as an effective tumor biomarker for patients with nasopharyngeal carcinoma (124 — 129)

X. M. SONG, S. Z. WANG, Z. J. WANG, W. J. CAO, J. L., F. CHEN

DOI: 10.4149/neo_2015_016

Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas (130 — 139)

P. KUGLIK, K. KASIKOVA, J. SMETANA, V. VALLOVA, A. LASTUVKOVA, L. MOUKOVA, M. CVANOVA, L. BROZOVA

DOI: 10.4149/neo_2015_017

Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment (140 — 145)

P. DVORAK, D. LYSAK, S. VOKURKA, M. KARAS, I. SUBRT

DOI: 10.4149/neo_2015_018

Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experienc (146 — 151)

T. SZOTKOWSKI, E. FABER, J. HUBACEK, L. RAIDA, P. ROHON, A. KUBA, Z. PIKALOVA, M. HOLZEROVA, M. DIVOKA, M. JAROSOVA, J. VRBKOVA, T. PAPAJIK, K. INDRAK

DOI: 10.4149/neo_2015_019

GROα expression and its prognostic implications in laryngeal squamous cell carcinoma (152 — 158)

L. HAN, W. LIU, Y. CHEN, H. WU, Y. ZHANG, B. JIANG

DOI: 10.4149/neo_2015_020

Management of patients with clinical stage I nonseminomatous germ cell testicular cancer: Active surveillance versus adjuvant chemotherapy – single-centre experience (159 — 163)

D. ONDRUS, M. ONDRUSOVA, K. KAJO

DOI: 10.4149/neo_2015_001